Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03138889
Brief Title: Bempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid Tumors (PROPEL)

First Submitted : May 1, 2017
First Submitted that Met QC Criteria : May 1, 2017
First Posted : May 3, 2017

Last Update Submitted that Met QC Criteria : July 28, 2021
Last Update Posted : July 30, 2021 (Estimate)